A semi-automated ASC speck assay to evaluate pyrin inflammasome activation

  • Pei Dai
  • , Oliver Skinner
  • , Xufeng Lin
  • , Aiden Telfser
  • , Stephanie Ruiz-Diaz
  • , Rohit G. Saldanha
  • , Katie Frith
  • , Ming Wei Lin
  • , Kahn Preece
  • , Paul E. Gray
  • , Alberto Pinzon-Charry
  • , Anna Sullivan
  • , Stephen Adelstein
  • , Winnie W.Y. Tong
  • , Matthew J.S. Parker
  • , Laila Girgis
  • , Brynn Wainstein
  • , Samar Ojami
  • , Elissa K. Deenick
  • , Leonard D. Goldstein
  • Michael J. Rogers, Tri Giang Phan

Research output: Contribution to journalArticlepeer-review

1 Downloads (Pure)

Abstract

Objective: To develop a rapid functional assay to validate variants of uncertain significance (VUS) in the MEFV gene. Methods: Overactivity of the pyrin inflammasome pathway and ASC speck oligomerisation in response to stimulation with low concentrations of Clostridium difficile toxin A was directly visualised by immunofluorescence microscopy. A semi-automated algorithm was developed to count cells and ASC specks. Results: The semi-automated ASC speck assay is able to discriminate between healthy controls and patients with familial Mediterranean fever (FMF) and pyrin inflammasome overactivity with high sensitivity. It is also able to discriminate pyrin inflammasome overactivity from other autoinflammatory disease controls with high specificity. Conclusion: The semi-automated ASC speck assay may be a useful test to functionally validate VUS in the MEFV gene and screen for pyrin inflammasome overactivity.

Original languageEnglish
Article numbere70054
Number of pages9
JournalClinical and Translational Immunology
Volume14
Issue number10
DOIs
Publication statusPublished - 2025

Keywords

  • ASC speck
  • functional testing
  • inflammasome
  • MEFV
  • pyrin
  • VUS

Fingerprint

Dive into the research topics of 'A semi-automated ASC speck assay to evaluate pyrin inflammasome activation'. Together they form a unique fingerprint.

Cite this